Avid Bioservices Inc (CDMO)

[pphmtoolong]

CsForH, my guestimates for the Sunrise look-ins were just based on:

1. Close to 500 patients would have been treated by the end of September of this year for the enrollment to be "on track".

2. Bavi-arm patients would survive 12 months to 7 months for the SOC patients, reflecting the numbers from the very similar Phase II Bavi study in NSCLC.

3. Review time by the Data Monitoring Committee would be two weeks. How much time do they need to review data that they are monitoring during the entire trial?

In the absence of any actual patient enrollment or ECOG data, just a guess. Actual results could be sooner or later.

Paul